Centric Health Corp. (TSE:CRX – Free Report) – Equities research analysts at Ventum Cap Mkts decreased their FY2024 EPS estimates for shares of Centric Health in a research note issued on Monday, November 11th. Ventum Cap Mkts analyst S. Quenneville now expects that the company will earn ($0.05) per share for the year, down from their previous estimate of ($0.04). Ventum Cap Mkts currently has a “Strong-Buy” rating on the stock.
Separately, Stifel Canada cut shares of Centric Health from a “strong-buy” rating to a “hold” rating in a research note on Monday, August 12th.
Centric Health Price Performance
Read More
- Five stocks we like better than Centric Health
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Shopify Stock Rally Continues: Why the Growth Story Isn’t Over
- Investing In Automotive Stocks
- Tariff Troubles: 3 Stocks Planning Higher Prices
- 3 Fintech Stocks With Good 2021 Prospects
- Mercer Near Rock Bottom: Is This High-Yield Play Set to Soar?
Receive News & Ratings for Centric Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centric Health and related companies with MarketBeat.com's FREE daily email newsletter.
